Brian M. Hahn
2023
In 2023, Brian M. Hahn earned a total compensation of $1.3M as Chief Financial Officer and Senior Vice President at GlycoMimetics, a 42% increase compared to previous year.
Compensation breakdown
| Bonus | $154,679 |
|---|---|
| Non-Equity Incentive Plan | $196,004 |
| Option Awards | $477,822 |
| Salary | $461,009 |
| Other | $10,425 |
| Total | $1,299,939 |
Hahn received $477.8K in option awards, accounting for 37% of the total pay in 2023.
Hahn also received $154.7K in bonus, $196K in non-equity incentive plan, $461K in salary and $10.4K in other compensation.
Rankings
In 2023, Brian M. Hahn's compensation ranked 933rd out of 3,006 executives tracked by ExecPay. In other words, Hahn earned more than 69.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 933 out of 3,006 | 69th |
Division Manufacturing | 550 out of 1,650 | 67th |
Major group Chemicals And Allied Products | 374 out of 918 | 59th |
Industry group Drugs | 363 out of 881 | 59th |
Industry Pharmaceutical Preparations | 247 out of 637 | 61st |
Source: SEC filing on April 1, 2024.
Hahn's colleagues
We found two more compensation records of executives who worked with Brian M. Hahn at GlycoMimetics in 2023.
News
GlycoMimetics CEO Harout Semerjian's 2023 pay jumps 67% to $2.4M
April 1, 2024
GlycoMimetics CEO Harout Semerjian's 2022 pay falls 50% to $1.4M
April 21, 2023
GlycoMimetics CEO Harout Semerjian receives $2.9M in 2021
April 11, 2022
GlycoMimetics CEO Rachel King's 2018 pay jumps 105% to $3.2M
April 10, 2019